Covid-19 Coronavirus

Patient Group Direction (PGD) library

Withdrawal Notice of some GSL/P medicines PGDs

As of 1 April 2024 some General Sale List (GSL) or Pharmacy (P) medicine PGDs are having to be withdrawn:

  • PGD 59 - Peppermint Oil 0.2ml capsules for abdominal colic, abdominal distention particularly in IBS and excessive trapped wind

  • PGD 65 - Senna 7.5mg and 15mg tablets, 7.5mg/5ml oral suspension for constipation

  • PGD 67 - Sodium Alginate with Potassium Bicarbonate suspension 20mg/100mg per ml, chewable tablets 100mg/500mg per tablet for management of mild symptoms of dyspepsia and gatro-oesophageal reflux disease

  • PGD 90 - Ibuprofen tablets and liquid for inflammation and soft tissue injury

  • PGD 96 - Hydroxocobalamin injection 1000 micrograms for Vitamin B12 deficiency

  • PGD 103 - Ibuprofen tablets and liquid for Pyrexia with discomfort

BNF Update

The BNF online access has been resolved for all primary and secondary users via IP addresses.  However, if you are working outside of the addresses given, you may experience difficulties accessing the BNF links.  You are welcome to seek support by emailing

Welcome to the Isle of Man Manx Care Patient Group Direction (PGD) library. 

PGD’s allow healthcare professionals to supply and administer specified medicines to pre-defined groups of patients, without a prescription and are used in line with legislation, so that patients have safe and speedy access to the medicines they need.

A policy for the Implementation, Utilisation And Authorisation of Patient Group Directions defines that only registered healthcare professionals that have attended Manx Care PGD training and have a completed competency book are legally authorised to use PGD’s.

The PGD’s in this library are not signed in order to comply with GDPR regulations regarding staff personal details. By appearing in this library, Manx Care confirms that the master PGD is valid and signed in accordance with the policy. Any staff member wishing to view a signed PGD can request this by contacting any member of the PGD group.

There are some PGD documents which have been scanned and aren't searchable. If you need any of these in an alternative format, please contact us via email at or by phone at +44 1624 685166.


Chlorhexdine with Lidocaine Gel for Urethral sounding and catheterisation - PGD 11

Chlorphenamine Maleate for Symptomatic relief of allergic reaction - PGD 12

Ciprofloxacin for suspected Neutropenic Sepsis - PGD 13

Clarithromycin 250mg tablets and suspension 125mg/5ml and suspension 250mg/5ml for Otitis Media - PGD 14

Clotrimazole pessary for Vulvo-vaginal candidiasis - PGD 15

Co-Amoxiclav tablets 500/125mg and Co-Amoxiclav suspension 125/31mg and 250/62mg for treatment of prophylaxis of infection following animal or human bites - PGD 16

Clopidogrel 75mg tablet for acute coronary syndrome - PGD 34

Cleen Ready to use Enema - Sodium Dihydrogan Phosphate Dehydrate - planned day case flexible sigmoidoscopy investigation, requiring a rectal bowel cleansing agent - PGD 77

Ceftriaxone 1g powder for injection vials for meningitis - PGD 81

Combined Transdermal Patch (EVRA(r)) for contraception - PGD 82

Carbocisteine 250mg in 5ml oral liquid for reduction of sputum viscosity - PGD 89

Co-codamol 30-500mg tablets for acute moderate pain - PGD 97

Cyclopentolate Hydrochloride Sterile eye drops 1% for dilating the eye - PGD 98

Codeine Phosphate for acute moderate to severe pain - PGD 108

Combined Oral Hormonal Contraception (COC) - PGD 142

Chloramphenicol eye drops or ointment (superficial eye infections) - PGD 145

Combined Oral Hormonal contraception (COC) for control of problematic bleeding - PGD 146

Contraceptive - Ulipristal acetate 30mg tablet - PGD 150

Cefalexin 250mg & 500mg tablets or capsules and 125mg/5ml & 250mg/5ml oral solution for mild group A streptococcal infections - PGD 168

Clarithomycin 250mg or 500mg tablets and 125mg/5ml or 250mg/5ml oral solution for mild group A streptococcal infections - PGD 169


5 to 17 years of age - Manx Care Patient Group Direction for COVID-19 mRNA vaccine

Adults - Manx Care Patient Group Direction for Administration of COVID-19 vaccine

5 to 17 years of age - UK COVID-19 mRNA vaccine Patient Group Direction

Adults - UK COVID-19 vaccine Patient Group Direction













Back to top